Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial (Q36379813)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial |
scientific article |
Statements
1 reference
Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial (English)
1 reference
Denise A Yardley
1 reference
Joyce O'Shaughnessy
1 reference
Adam Brufsky
1 reference
Robert E Coleman
1 reference
Stefan Glück
1 reference
Jean-Mark A Nabholtz
1 reference
Robert M Beck
1 reference
Amy Ko
1 reference
Markus F Renschler
1 reference
Debora Barton
1 reference
Identifiers
1 reference